Aarnoutse, Rob <br/><br/>
Reply to "strategy to limit sampling of antituberculosis drugs instead of determining concentrations at two hours postingestion in relation to treatment response".  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  2014 
 - 629-30 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01651-13  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--pharmacokinetics<br/>Female<br/>Humans<br/>Isoniazid--pharmacokinetics<br/>Male<br/>Pyrazinamide--pharmacokinetics<br/>Rifampin--pharmacokinetics<br/>Tuberculosis, Pulmonary--drug therapy